Yishen Xiaoke Formula Delays Renal Fibrosis in Rats with Diabetic Nephropathy by Suppressing the Transforming Growth Factor-Beta 1/Notch Signalling Pathway.

Authors

Shanshan Chang, Xuan Zheng, Qiang Chen, Xuan Liu, Jianhong Zhang

Published in

Iranian journal of pharmaceutical research : IJPR. Volume 25. Issue 1. Pages e171242. Epub Sep 23, 2026.

Abstract

Yishen Xiaoke Formula (YSXKF), derived from the classical prescription Yuquan San, has been used clinically to treat diabetic nephropathy (DN) in patients with qi-yin deficiency syndrome.
This study investigated whether YSXKF delays renal fibrosis progression in DN rats by regulating the transforming growth factor-beta 1 (TGF-β1)/Notch signalling pathway.
Seventy-five male Sprague Dawley rats were included and randomly assigned to a control cohort (15 rats) or a model cohort (60 rats). DN was induced by unilateral nephrectomy, a high-fat/high-sucrose diet, and streptozotocin injection. DN rats were treated with YSXKF, irbesartan, or YSXKF combined with TGF-β1 activation for 8 weeks. After 8 weeks of intervention, 24-h urinary total protein (24-h UTP), circulating TGF-β1 levels, fasting blood glucose (FBG), and serum creatinine (Scr) were evaluated. Masson staining was performed to assess renal pathological changes, and quantitative reverse transcription polymerase chain reaction and immunohistochemistry were conducted to assess the levels of TGF-β1, Jagged1, and Hes1 in renal tissue.
Compared with DN rats, YSXKF treatment significantly reduced 24-h UTP excretion, circulating TGF-β1 levels, FBG, and Scr. Histological analysis revealed attenuated glomerulosclerosis and interstitial fibrosis. YSXKF decreased renal mRNA and protein expression of TGF-β1, Jagged1, and Hes1. Activation of TGF-β1 markedly reversed these protective effects and restored Notch pathway activation.
YSXKF delays renal fibrosis progression in DN rats by downregulating TGF-β1 expression and inhibiting Jagged1/Hes1 activation in the Notch signaling pathway, thereby reducing extracellular matrix deposition.

PMID:
42871587
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.